Bangladeshi (DSE) Pharma Industry Analysis
UpdatedMay 30, 2023
DataAggregated Company Financials
Companies17
- 7D0.3%
- 3M-1.7%
- 1Y-4.8%
- YTD-1.9%
Over the last 7 days, the Pharma industry has remained flat, although notably Navana Pharmaceuticals gained 18%. Unfortunately though, the industry is down 4.8% over the past 12 months. Looking forward, earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Bangladeshi Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 30 May 2023 | ৳529.7b | ৳202.1b | ৳31.8b | 30.3x | 16.6x | 2.6x |
| Thu, 27 Apr 2023 | ৳527.1b | ৳197.0b | ৳33.4b | 29.2x | 15.8x | 2.7x |
| Sat, 25 Mar 2023 | ৳529.7b | ৳197.0b | ৳33.4b | 26.1x | 15.9x | 2.7x |
| Mon, 20 Feb 2023 | ৳540.4b | ৳197.0b | ৳33.4b | 26.9x | 16.2x | 2.7x |
| Wed, 18 Jan 2023 | ৳546.6b | ৳189.6b | ৳33.9b | 28.5x | 16.1x | 2.9x |
| Fri, 16 Dec 2022 | ৳550.2b | ৳190.0b | ৳34.1b | 24.7x | 16.1x | 2.9x |
| Sun, 13 Nov 2022 | ৳569.1b | ৳176.6b | ৳34.3b | 24.7x | 16.6x | 3.2x |
| Tue, 11 Oct 2022 | ৳576.0b | ৳172.0b | ৳34.7b | 24.2x | 16.6x | 3.3x |
| Thu, 08 Sep 2022 | ৳554.2b | ৳172.6b | ৳34.7b | 25.4x | 16x | 3.2x |
| Sat, 06 Aug 2022 | ৳533.2b | ৳172.6b | ৳34.7b | 22.4x | 15.3x | 3.1x |
| Mon, 04 Jul 2022 | ৳531.2b | ৳172.6b | ৳34.7b | 21.3x | 15.3x | 3.1x |
| Wed, 01 Jun 2022 | ৳545.9b | ৳172.6b | ৳34.7b | 22.5x | 15.7x | 3.2x |
| Fri, 29 Apr 2022 | ৳554.0b | ৳169.2b | ৳34.3b | 24.8x | 16.1x | 3.3x |
| Sun, 27 Mar 2022 | ৳548.5b | ৳169.2b | ৳34.3b | 25.8x | 16x | 3.2x |
| Tue, 22 Feb 2022 | ৳559.2b | ৳169.3b | ৳34.4b | 22.7x | 16.3x | 3.3x |
| Thu, 20 Jan 2022 | ৳557.1b | ৳166.7b | ৳32.5b | 23.8x | 17.1x | 3.3x |
| Sat, 18 Dec 2021 | ৳551.3b | ৳158.8b | ৳30.3b | 22.4x | 18.2x | 3.5x |
| Mon, 15 Nov 2021 | ৳555.0b | ৳148.4b | ৳26.4b | 27.2x | 21x | 3.7x |
| Wed, 13 Oct 2021 | ৳602.3b | ৳145.3b | ৳25.4b | 30.1x | 23.7x | 4.1x |
| Fri, 10 Sep 2021 | ৳584.4b | ৳151.7b | ৳25.7b | 26.7x | 22.7x | 3.9x |
| Sun, 08 Aug 2021 | ৳536.0b | ৳151.7b | ৳25.7b | 27.4x | 20.9x | 3.5x |
| Sat, 01 May 2021 | ৳474.2b | ৳151.7b | ৳25.7b | 18.9x | 18.5x | 3.1x |
| Tue, 02 Feb 2021 | ৳470.5b | ৳148.4b | ৳24.6b | 21.7x | 19.1x | 3.2x |
| Fri, 06 Nov 2020 | ৳388.6b | ৳143.5b | ৳23.9b | 19.6x | 16.3x | 2.7x |
| Mon, 10 Aug 2020 | ৳348.5b | ৳139.4b | ৳23.0b | 19.2x | 15.2x | 2.5x |
Price to Earnings Ratio
13.9x
Current Industry PE
- Investors are relatively neutral on the Bangladeshi Pharmaceuticals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PE ratio of 17.2x.
- The 3-year average PS ratio of 3.1x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have grown 8.8% per year over the last three years.
- Revenues for these companies have grown 13% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Bangladeshi Healthcare industry?
| BD Market | 0.62% | |
| Healthcare | 0.42% | |
| Pharma | 0.30% | |
| Pharma | 0.30% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| NAVANAPHAR Navana Pharmaceuticals | ৳107.30 | 21.7% +৳2.1b | n/a | PE34.9x | |
| ACMELAB ACME Laboratories | ৳87.50 | 2.1% +৳380.9m | -1.4% | PE8.4x | |
| ADVENT Advent Pharma | ৳27.30 | 4.6% +৳111.8m | 6.6% | PE25.8x | |
| SILCOPHL Silco Pharmaceuticals | ৳24.70 | 2.9% +৳72.7m | -14.8% | PE29x | |
| LIBRAINFU Libra Infusions | ৳703.30 | 0.9% +৳9.9m | -16.2% | n/a |